Table 3 Proportion of infants receiving immunizations and attending complete continuum of care
Unadjusted | Adjusteda | ||||
|---|---|---|---|---|---|
Intervention (proportion with CI) n = 87 | Control (proportion with CI) n = 90 | p-value | Intervention vs control | ||
Odds ratio (CI) | p-value | ||||
Birth: BCG | 0.99 (0.86–0.99) | 0.97 (0.83–0.99) | 0.40 | 3.45 (0.10–122) | 0.41 |
Birth: OPV1 | 0.97 (0.65–0.99) | 0.97 (0.83–0.99) | 0.98 | 1.06 (0.03–35.18) | 0.97 |
6 weeks: OPV2 | 0.99 (0.86–0.99) | 0.98 (0.85–0.99) | 0.62 | 1.05 (0.01–179.47) | 0.98 |
6 weeks: RV1 | 0.99 (0.86–0.99) | 0.98 (0.85–0.99) | 0.62 | 1.05 (0.01–179.47) | 0.98 |
6 weeks: Dtap-IPV-Hib1 | 0.99 (0.96–0.99) | 0.97 (0.93–0.98) | 0.12 | 2.83 (0.69–11.64) | 0.12 |
6 weeks: PCV1 | 0.99 (0.86–0.99) | 0.98 (0.85–0.99) | 0.62 | 1.05 (0.01–179.47) | 0.98 |
6 weeks: Hep B1 | 0.99 (0.86–0.99) | 0.98 (0.85–0.99) | 0.62 | 1.41 (0.06–35.67) | 0.80 |
10 weeks: Dtap-IPV-Hib2 | 0.98 (0.96–0.99) | 0.97 (0.94–0.98) | 0.33 | – | - |
10 weeks: Hep B2 | 1 | 0.98 (0.97–0.98) | 0.12 | 1 | - |
14 weeks: Dtap-IPV-Hib3 | 1 | 0.94 (0.91–0.97) | 0.12 | 1 | - |
14 weeks: Hep B3 | 0.99 (0.86–0.99) | 0.97 (0.78–0.99) | 0.43 | 2.83 (0.08–96.75) | 0.76 |
14 weeks: PCV2 | 0.98 (0.75–0.99) | 0.97 (0.78–0.99) | 0.78 | 1.50 (0.05–45.45) | 0.77 |
14 weeks: RV2 | 0.97 (0.88–0.99) | 0.96 (0.88–0.98) | 0.71 | 1.53 (0.25–9.48) | 0.58 |
9 months: Measles1 | 1 | 0.94 (0.82–0.98) | 0.22 | 1 | |
9 months: PCV3 | 0.98 (0.96–0.99) | 0.94 (0.82–0.98) | 0.16 | 2.38 (0.60–9.42) | 0.17 |
Fully immunized | 0.95 (0.91–1) | 0.89 (0.82–0.96) | 0.11 | 1.73 (0.54–5.52) | 0.282 |
Attending at least 4 ANC visits and fully immunized up to 1 year (complete continuum of care) | |||||
0.7 (0.60–0.80) | 0.41 (0.31–0.51) | 0.00 | 3.2 (1.63–6.31) | 0.007 | |